Counterfeit and substandard drugs in India may be smaller problem than claimed, say government findings
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g60 (Published 07 January 2014) Cite this as: BMJ 2014;348:g60- Cheryl Travasso
- 1Mumbai
Only a very small fraction (0.05%) of drugs made in India and tested by the Central Drugs Standard Control Organisation between 2009 and 2012 were “spurious” (counterfeit) or substandard, government data have shown.
In 2009 the drugs agency published its Report on Countrywide Survey for Spurious Drugs concerning what it believed were mostly unverified and sensational reports that between 10% and 25% of Indian drugs were “spurious.”1 Spurious drugs are defined as those that are manufactured under another drug name or that wrongly claim to be …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.